News

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal.
Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
Welcome to The Globe and Mail’s business and investing news quiz. Join us each week to test your knowledge of the stories making headlines. Our business reporters come up with the questions, and you ...
Weight loss drugs pose a danger to boys and men. A study of the drugs Ozempic and Wegovy found that males who used them ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...
More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...
Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...